collection
https://read.qxmd.com/read/26314780/cancer-of-the-pancreas-esmo-clinical-practice-guidelines-for-diagnosis-treatment-and-follow-up
#1
JOURNAL ARTICLE
M Ducreux, A Sa Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, T Seufferlein, K Haustermans, J L Van Laethem, T Conroy, D Arnold
No abstract text is available yet for this article.
September 2015: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://read.qxmd.com/read/26846177/factors-associated-with-failure-to-complete-adjuvant-chemotherapy-in-pancreatic-cancer
#2
JOURNAL ARTICLE
Takahiro Akahori, Masayuki Sho, Toshihiro Tanaka, Shoichi Kinoshita, Minako Nagai, Satoshi Nishiwada, Hideyuki Nishiofuku, Chiho Ohbayashi, Kimihiko Kichikawa, Yoshiyuki Nakajima
BACKGROUND: The importance of completing adjuvant chemotherapy in pancreatic cancer is becoming recognized. However, the clinicopathological factors associated with failure to complete adjuvant chemotherapy remain unclear. METHODS: A total of 135 patients were analyzed to identify the factors associated with failure to complete adjuvant chemotherapy. RESULTS: Ninety patients completed planned adjuvant chemotherapy, whereas 45 patients failed to complete adjuvant chemotherapy...
April 2016: American Journal of Surgery
https://read.qxmd.com/read/23856911/recent-progress-in-pancreatic-cancer
#3
REVIEW
Christopher L Wolfgang, Joseph M Herman, Daniel A Laheru, Alison P Klein, Michael A Erdek, Elliot K Fishman, Ralph H Hruban
Pancreatic cancer is currently one of the deadliest of the solid malignancies. However, surgery to resect neoplasms of the pancreas is safer and less invasive than ever, novel drug combinations have been shown to improve survival, advances in radiation therapy have resulted in less toxicity, and enormous strides have been made in the understanding of the fundamental genetics of pancreatic cancer. These advances provide hope but they also increase the complexity of caring for patients. It is clear that multidisciplinary care that provides comprehensive and coordinated evaluation and treatment is the most effective way to manage patients with pancreatic cancer...
September 2013: CA: a Cancer Journal for Clinicians
https://read.qxmd.com/read/26335256/incidence-and-prognostic-impact-of-para-aortic-lymph-nodes-metastases-during-pancreaticoduodenectomy-for-peri-ampullary-cancer
#4
JOURNAL ARTICLE
Gennaro Nappo, Domenico Borzomati, Giuseppe Perrone, Sergio Valeri, Michela Amato, Tommasangelo Petitti, Roberto Coppola
BACKGROUND: Standard lymphadenectomy during pancreaticoduodenectomy (PD) for peri-ampullary cancer does not include the routine removal of para-aortic lymph nodes (PALN) (station 16, according to the JPS staging system). The aim of this study was to report the incidence and the prognostic value of PALN metastases in patients undergoing PD for peri-ampullary cancer. MATERIALS AND METHODS: One hundred thirty-five consecutive patients who underwent PD and PALN dissection for peri-ampullary cancer were prospectively evaluated...
November 2015: HPB: the Official Journal of the International Hepato Pancreato Biliary Association
https://read.qxmd.com/read/26344400/effects-of-antecolic-versus-retrocolic-reconstruction-for-gastro-duodenojejunostomy-on-delayed-gastric-emptying-after-pancreatoduodenectomy-a-systematic-review-and-meta-analysis
#5
REVIEW
Masafumi Imamura, Yasutoshi Kimura, Tatsuya Ito, Takuro Kyuno, Takayuki Nobuoka, Toru Mizuguchi, Koichi Hirata
BACKGROUND: Delayed gastric emptying (DGE) is a relatively common complication after pancreatoduodenectomy (PD). The aim of this study was to determine whether DGE is affected by antecolic or retrocolic reconstruction for gastro/duodenojejunostomy after PD. METHODS: A literature search was performed of the MEDLINE (PubMed), Ovid SP, ISI Web of Knowledge, EMBASE, and Cochrane databases to identify randomized controlled trials (RCTs) and clinical observational studies related to this topic from January 1995 to November 2014...
January 2016: Journal of Surgical Research
https://read.qxmd.com/read/20622661/early-versus-late-drain-removal-after-standard-pancreatic-resections-results-of-a-prospective-randomized-trial
#6
RANDOMIZED CONTROLLED TRIAL
Claudio Bassi, Enrico Molinari, Giuseppe Malleo, Stefano Crippa, Giovanni Butturini, Roberto Salvia, Giorgio Talamini, Paolo Pederzoli
SUMMARY OF BACKGROUND DATA: The role of surgically placed intra-abdominal drainages after pancreatic resections has not been clearly established. In particular, their effect on morbidity rates and the optimal timing for their removal remains controversial. METHODS: A total of 114 eligible patients who underwent standard pancreatic resections and at low risk of postoperative pancreatic fistula according to our institutional protocol (amylase value in drains < or =5000 U/L on postoperative day [POD] 1) were randomized on POD 3 to receive either early (POD 3) or standard drain removal (POD 5 or beyond)...
August 2010: Annals of Surgery
https://read.qxmd.com/read/24979599/pancreatectomy-predicts-improved-survival-for-pancreatic-adenocarcinoma-results-of-an-instrumental-variable-analysis
#7
JOURNAL ARTICLE
Bradley D McDowell, Cole G Chapman, Brian J Smith, Anna M Button, Elizabeth A Chrischilles, James J Mezhir
BACKGROUND AND OBJECTIVE: Pancreatic resection is the standard treatment option for patients with stage I/II pancreatic ductal adenocarcinoma (PDA), yet many studies demonstrate low rates of resection. The objective of this study was to evaluate whether increasing resection rates would result in an increase in average survival in patients with stage I/II PDA. METHODS: SEER (Surveillance, Epidemiology, and End Results) data were analyzed for patients with stage I/II pancreatic head cancers treated from 2004 to 2009...
April 2015: Annals of Surgery
https://read.qxmd.com/read/24979603/pancreatic-adenocarcinoma-number-of-positive-nodes-allows-to-distinguish-several-n-categories
#8
JOURNAL ARTICLE
Oliver Strobel, Ulf Hinz, Alexander Gluth, Thomas Hank, Thilo Hackert, Frank Bergmann, Jens Werner, Markus W Büchler
OBJECTIVE: To determine the prognostic value of PLN and LNR based on a large series with standardized lymphadenectomy and pathological workup. BACKGROUND: Lymph node (LN) involvement is a major prognostic factor in pancreatic adenocarcinoma. However, the distinction N0/N1 is not sufficient to accurately predict prognosis. To improve prognostic accuracy in N1 tumors, different LN parameters have been tested. Previous studies were based on series with variable numbers of examined lymph nodes (ELN) and came to inconsistent conclusions as to the value of the number of positive lymph nodes (PLN) and the lymph node ratio (LNR)...
May 2015: Annals of Surgery
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.